
In an effort to target these harmful processes and protect the body while still allowing the virus to be eradicated, a team from the Schulich School of Medicine & Dentistry and Lawson Health Research Institute are the first in the world to profile the bodys immune response to COVID-19. By studying blood samples from critically ill patients the research team identified a unique pattern of six molecules that could be used as therapeutic targets to treat the virus. The study was published in Critical Care Explorations….